Cecilia Ladines-Llave
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cecilia Ladines-Llave has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alvin Duke R. Sy
Department of Epidemiology and Biostatistics, College of Public Health, University of the Philippines Manila, Philippines
1 shared publication - Chika Yamada
Center for Southeast Asian Studies, Kyoto University, Kyoto, Japan
1 shared publication Haidee A. Valverde
Institute of Health Policy and Development Studies, University of the Philippines Manila-National Institutes of Health, Manila, Philippines
1 shared publicationHiroya Matsuo
Department of Public Health, Graduate School of Health Sciences, Kobe University, Kobe, Japan
1 shared publicationJessica Mooney
Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA
1 shared publication- Josephine G. Aldaba
Institute of Child Health and Human Development, University of the Philippines Manila-National Institutes of Health, Manila, Philippines
1 shared publication
Latest Publications
- Open Access
- 17 February 2024
- Published by Elsevier in Vaccine: X
- Vol. 17, 100459
The cost of human papillomavirus vaccination delivery at the administrative and health facility levels in the Philippines
- 17 February 2024
- Published by Elsevier in Vaccine: X
- Vol. 17, 100459
Open AccessThe cost of human papillomavirus vaccination delivery at the administrative and health facility levels in the Philippines
- Open Access
- 1 March 2021
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 15, 501-510
Maternal Knowledge Associated with the Prevalence of Iron and Folic Acid Supplementation Among Pregnant Women in Muntinlupa, Philippines: A Cross-Sectional Study
Purpose: The World Health Organization advocates that all pregnant women in areas where anemia is prevalent receive supplements of iron and folic acid. However, owing to a myriad of factors, the uptake of iron and folic acid supplementation (IFAS) is still low in many countries. Therefore, this study was conducted to assess the prevalence of IFAS and its associated factors among pregnant women. Patients and Methods: A cross-sectional study was conducted at a hospital in Muntinlupa, Philippines, between March and August 2019 among 280 pregnant women. A systematic random sampling technique was used to select participants. Data were collected using interviewer-administered questionnaires. Multivariable logistic regression analyses were employed to identify factors associated with the prevalence of IFAS among pregnant women. Results: Among 280 pregnant women, a majority (85.6%, n= 238) took IFAS during pregnancy. Among the respondents, 128 (45.9%) women had knowledge about signs and symptoms of anemia, 126 (45.3%) had knowledge of the benefits associated with IFAS, and 42 (15.4%) had knowledge about side effects associated with IFAS. The main sources of information about IFAS were health care providers (41.8%), followed by community health workers (CHWs) (14.6%). Maternal knowledge concerning IFAS benefits (OR = 2.50, CI = 1.04– 5.97, p=0.04) was positively associated with the prevalence of IFAS. Conclusion: Maternal knowledge about the benefits of taking IFAS was significantly associated with the prevalence of IFAS among pregnant women in Muntinlupa, Philippines. There is a pressing need to improve health education on the benefits of IFAS among pregnant women to increase its prevalence. This emphasizes the necessity of increased involvement of health care providers and CHWs to increase women’s knowledge of IFAS benefits and support them through pregnancy.
- 1 March 2021
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 15, 501-510
Open AccessMaternal Knowledge Associated with the Prevalence of Iron and Folic Acid Supplementation Among Pregnant Women in Muntinlupa, Philippines: A Cross-Sectional Study
Purpose: The World Health Organization advocates that all pregnant women in areas where anemia is prevalent receive supplements of iron and folic acid. However, owing to a myriad of factors, the uptake of iron and folic acid supplementation (IFAS) is still low in many countries. Therefore, this study was conducted to assess the prevalence of IFAS and its associated factors among pregnant women. Patients and Methods: A cross-sectional study was conducted at a hospital in Muntinlupa, Philippines, between March and August 2019 among 280 pregnant women. A systematic random sampling technique was used to select participants. Data were collected using interviewer-administered questionnaires. Multivariable logistic regression analyses were employed to identify factors associated with the prevalence of IFAS among pregnant women. Results: Among 280 pregnant women, a majority (85.6%, n= 238) took IFAS during pregnancy. Among the respondents, 128 (45.9%) women had knowledge about signs and symptoms of anemia, 126 (45.3%) had knowledge of the benefits associated with IFAS, and 42 (15.4%) had knowledge about side effects associated with IFAS. The main sources of information about IFAS were health care providers (41.8%), followed by community health workers (CHWs) (14.6%). Maternal knowledge concerning IFAS benefits (OR = 2.50, CI = 1.04– 5.97, p=0.04) was positively associated with the prevalence of IFAS. Conclusion: Maternal knowledge about the benefits of taking IFAS was significantly associated with the prevalence of IFAS among pregnant women in Muntinlupa, Philippines. There is a pressing need to improve health education on the benefits of IFAS among pregnant women to increase its prevalence. This emphasizes the necessity of increased involvement of health care providers and CHWs to increase women’s knowledge of IFAS benefits and support them through pregnancy.